IN the last decade many investigators have demonstrated that the administration of vasopressor drugs may terminate paroxysmal supraventricular and ventricular tachycardia. 1–11 However, it is only ...

Both dopamine and norepinephrine are recommended as first-line vasopressor agents in the treatment of shock. There is a continuing controversy about whether one agent is superior to the other. In this ...

With this in mind, the recent VANISH trial [4] sought to determine whether AVP in higher than previously used doses (up to 0.06 U/min) would improve renal outcomes compared with norepinephrine.

In sepsis patients who require high-dose vasopressors, despite keeping central venous pressure (CVP) in the range of 12-15 mmHg, how do you prevent acute renal failure? High doses of norepinephrine ...

Results of an Electronic Health Record (EHR) study assessing the most commonly used medications for raising blood pressure in patients with nontraumatic subarachnoid hemorrhage (SAH), a rare type of ...

The Business Research Company's Vasopressor Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 The Business Research Company's Latest Report Explores Market Driver, Trends, ...

A full consensus has not been reached about the hemodynamic efficacy of hydrocortisone administration in hypotensive and vasopressor-dependent preterm neonates. Standard meta-analytic techniques, ...

SAN FRANCISCO -- For sepsis-induced hypotension, a restrictive fluid strategy with earlier vasopressor use didn't impact mortality compared with liberal fluids, the CLOVERS trial showed. The ...

Despite advancements in sepsis management, mortality rates remain high. In 2011, 1 in 18 deaths in Canada involved sepsis.1 Delays in achieving adequate mean arterial pressure (MAP) are associated ...